SCHEMBL7094698

SCHEMBL7094698

Oc1ccc(-c2n[nH]c3c2sc2ccccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.43
HSP90AB1 P08238 1/20 0.43
FGFR1 P11362 2/20 0.42
FGFR2 P21802 2/20 0.42
FGFR3 P22607 1/20 0.42
MAPK1 P28482 3/20 0.41
MAP2K4 P45985 3/20 0.41
MAPKAPK2 P49137 3/20 0.41
MAPK6 Q16659 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
MAPT P10636 2/20 0.41
RAB9A P51151 2/20 0.41
PTPN1 P18031 2/20 0.40
MAPKAPK3 Q16644 2/20 0.39
MAPKAPK5 Q8IW41 1/20 0.39
HSP90AA1 P07900 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
GAA P10253 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7000848 0.88 ALDH1A1 (0.49) FGFR1MAP2K4MEN1KMT2AMAPT
SCHEMBL7095837 0.85 MEN1 (0.51) MAPK1MAP2K4MAPKAPK2MAPK6MEN1
SCHEMBL7090318 0.85 CSF1R (0.41) MAPK1MAP2K4MEN1KMT2AMAPT
SCHEMBL7096389 0.85 MAPT (0.41) FGFR1FGFR2MEN1KMT2AMAPT
SCHEMBL7091161 0.82 MAP2K4 (0.45) MAPK1MAP2K4MAPKAPK2MAPK6MAPKAPK3
SCHEMBL7698784 0.82 ALDH1A1 (0.46) MAPK1MEN1KMT2AMAPTRAB9A
SCHEMBL6994774 0.82 MEN1 (0.38) MAPK1MAP2K4MEN1KMT2AMAPT
SCHEMBL20035103 0.80 HTR2B (0.42) MAPKAPK2MEN1KMT2AMAPTRAB9A
SCHEMBL7097039 0.76 EGFR (0.42) MEN1KMT2ARAB9AALDH1A1NPC1
SCHEMBL7096045 0.75 LRRK2 (0.43) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed